RedHill Biopharma Ltd - Company Profile

Powered by

All the data and insights you need on RedHill Biopharma Ltd in one report.

  • Save hours of research time and resources with
    our up-to-date RedHill Biopharma Ltd Strategy Report

  • Understand RedHill Biopharma Ltd position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

RedHill Biopharma Ltd: Overview

RedHill Biopharma Ltd (RedHill) is a specialty biopharmaceutical company that develops and commercializes therapeutics for gastrointestinal (GI) diseases and cancer. The company’s commercial product portfolio consists of branded prescription drugs including a combination of omeprazole, amoxicillin and rifabutin omeprazole; naloxegol; and rifamycin. RedHill is investigating its pipeline candidates for the treatment of Crohn's disease, non-tuberculous mycobacterial infection (NTM) infections, gastroenteritis, gastritis, irritable bowel syndrome with diarrhea (IBS-D), bowel cleanser, cancer and novel coronavirus disease (COVID-19). The company has a subsidiary in the US. RedHill is headquartered in Tel Aviv, Israel.

Gain a 360-degree view of RedHill Biopharma Ltd and make more informed decisions for your business Gain a 360-degree view of RedHill Biopharma Ltd and make more informed decisions for your business Find out more
Headquarters Israel

Address 21 Ha'Arba'A St., Tel Aviv-Yafo, 6473921


Telephone 972 3 5413131

No of Employees 53

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange RDHL (NASD)

Revenue (2022) $6.5M -89.4% (2022 vs 2021)

EPS XYZ

Net Income (2022) XYZ 133.4% (2022 vs 2021)

Market Cap* $13.4M

Net Profit Margin (2022) XYZ 415.8% (2022 vs 2021)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

RedHill Biopharma Ltd premium industry data and analytics

60+

Clinical Trials

Determine RedHill Biopharma Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

40+

Catalyst Calendar

Proactively evaluate RedHill Biopharma Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

11+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

8

Pipeline Drugs

Identify which of RedHill Biopharma Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

5

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

3

Marketed Drugs

Understand RedHill Biopharma Ltd’s commercialized product portfolio to stay one step ahead of the market.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on RedHill Biopharma Ltd’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Prescription Drugs: Talicia
A combination of Omeprazole, Amoxicillin and Rifabutin Movantik
Naloxegol Aemcolo
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand RedHill Biopharma Ltd portfolio and identify potential areas for collaboration Understand RedHill Biopharma Ltd portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters RedHill Biopharma Ltd Hayat Pharmaceutical Industries BioLineRx Ltd SciSparc Ltd Notable Labs Ltd
Headquarters Israel Jordan Israel Israel United States of America
City Tel Aviv-Yafo Amman Modiin Tel Aviv-Yafo Foster City
State/Province - - - - California
No. of Employees 53 191 79 3 7
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Dror Ben-Asher Chairman; Chief Executive Officer Executive Board 2011 57
Rick D. Scruggs Director; Chief Commercial Officer Executive Board 2020 63
Razi Ingber Chief Financial Officer Senior Management 2023 39
Gilead Raday Chief Operating Officer Senior Management 2016 48
Kristin Comer Chief Compliance Officer; Vice President; General Counsel Senior Management - -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into RedHill Biopharma Ltd key executives to enhance your sales strategy Gain insight into RedHill Biopharma Ltd key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Why are you leaving?